← Eichor
Study identifier: NCT05774483 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative

Condition: Mouth Neoplasms · Oral Cancers · Oral Squamous Cell Carcinoma (OSCC)  ·  Sponsor: Tata Memorial Hospital

PhaseNA
Planned participants508
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to compare the survival outcomes, morbidity and cost-effectiveness of sentinel node biopsy versus limited elective neck dissection in node-negative early oral cancers. The main questions it aims to answer are: * Survival outcomes * Morbidity outcomes * Cost-effectiveness Participants will either undergo sentinel node biopsy followed by completion neck dissection if sentinel node is reported to be metastatic (SNB) or limited elective neck dissection where level IIb will be cleared only if level IIa is metastatic (limited END). The study will compare the outcomes in the two cohorts.

This description comes directly from the study's public registry record.

Talk to the study team

Richa Vaish, MS, M.Ch  ·  02224177000  ·  drvaishricha@gmail.com

Always discuss trial participation with your own doctor first.

Locations (3)

Tata Memorial HospitalMumbai, Maharashtra, IndiaRecruiting
ACTRECNavi Mumbai, Maharashtra, IndiaNot Yet Recruiting
Mpmmcc & HbchVaranasi, Uttar Pradesh, IndiaNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05774483